What is Pulse Biosciences, Inc.'s free cash flow margin?

Pulse Biosciences, Inc. (PLSE) reported free cash flow margin of -7,390% in Q1 2026.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Pulse Biosciences, Inc. PLSE Free cash flow margin

Free cash flow margin at other companies

AbbottABT

16.3%+0.6pp

Johnson & JohnsonJNJ

18.5%-4.3pp

Boston ScientificBSX

16.9%-0.3pp

MedtronicMDT

14.9%-0.5pp

Merit Medical SystemsMMSI

14.3%+1.3pp

ITG

Integer HoldingsITGR

5.4%-1.0pp

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.8B+38.4%

Enterprise value$1.73B+48.1%

P/S2,391.5×—

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

free cash flow/total revenue=-7,390%

Based on trailing twelve months.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s free cash flow margin?: Pulse Biosciences, Inc. (PLSE) reported free cash flow margin of -7,390% in Q1 2026.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.